Amfepramone, also known as diethylpropion, is a stimulant drug of the phenethylamine, amphetamine, and cathinone classes that is used as an appetite suppressant. It is used in the short-term management of obesity, along with dietary and lifestyle changes. Amfepramone is most closely chemically related to the antidepressant and smoking cessation aid bupropion (previously called a… WebBrand Name Equivalent: ... Diethylpropion hydrochloride and its metabolites have been shown to be excreted into breast milk. However, it is unknown if diethylpropion or its metabolites will cause harm to the nursing infant.2 Because of the potential for adverse effects in the nursing infants, breast-feeding while taking diethylpropion should be ...
Diethylpropion: Dosage, Mechanism/Onset of Action, Half-Life
WebJul 13, 2024 · Diethylpropion hydrochloride is a sympathomimetic agent. The chemical name for diethylpropion hydrochloride is 1-phenyl-2-diethyl-amino-1-propanone hydrochloride. Its chemical structure is: In … WebThe chemical name for diethylpropion hydrochloride is 1-phenyl-2-diethylamino-1-propanone hydrochloride. Its chemical structure is: CLINICAL PHARMACOLOGY Diethylpropion hydrochloride is a sympathomimetic amine with some pharmacologic activity similar to that of the prototype drugs of this class used in obesity, the … pbz transaction
Diethylpropion Oral: Uses, Side Effects, Interactions, …
WebMar 1, 2024 · The chemical name for Diethylpropion hydrochloride is 1-phenyl-2-diethylamino-1-propanone hydrochloride. Its chemical structure is: Diethylpropion - Clinical Pharmacology Diethylpropion hydrochloride is a sympathomimetic amine with some pharmacologic activity similar to that of the prototype drugs of this class used in … WebDiethylpropion hydrochloride International Programme on Chemical Safety Poison Information Monograph 937 Pharmaceutical 1. NAME 1.1 Substance ... Diethylpropion … WebDiethylpropion hydrochloride is indicated in the management of exogenous obesity as a short-term adjunct (a few weeks) in a regimen of weight reduction based on caloric restriction in patients with an initial body mass index (BMI) of 30 kg/m2 or higher and who have not responded to appropriate weight reducing regimen (diet and/or exercise) alone. pc 104 connector